Evidence map›Paper›PMID 38725870›Full record

ArticleFrontiers in molecular biosciences2024

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes.

Julia Sieminska, Katarzyna Miniewska, Robert Mroz, Ewa Sierko, Wojciech Naumnik, Joanna Kisluk, Anna Michalska-Falkowska, Joanna Reszec, Miroslaw Kozlowski, Lukasz Nowicki and 5 more

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Julia SieminskaMetabolomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Katarzyna MiniewskaMetabolomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Robert Mroz2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland.
Ewa SierkoDepartment of Oncology, Medical University of Bialystok, Bialystok, Poland.
Wojciech Naumnik1st Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland.
Joanna KislukDepartment of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland.
Anna Michalska-FalkowskaDepartment of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland.
Joanna ReszecDepartment of Medical Patomorphology, Medical University of Bialystok, Bialystok, Poland.
Miroslaw KozlowskiDepartment of Thoracic Surgery, Medical University of Bialystok, Bialystok, Poland.
Lukasz NowickiAltium International Sp. z o. o., Warszawa, Poland.
Marcin MoniuszkoDepartment of Allergology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Adam KretowskiMetabolomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Jacek NiklinskiDepartment of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland.
Michal CiborowskiMetabolomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
Joanna GodzienMetabolomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adenocarcioma ADClipidomicsmetabolomicsmonoacylglycerophosphatidic acid LPAnon-small cell lung cancer NSCLCoxidised glycerophosphatidylcholine oxPCsquamous call carcinoma SCC

Identifiers

PMID38725870
PMCPMC11079276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.